Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORINF:US

31.6000 USD 0.00000.00%

As of 20:10:03 ET on 03/20/2015.

Snapshot for Orion Oyj (ORINF)

Open: - Day's Range: - Volume: 100
Previous Close: 31.6000 52wk Range: 31.6000 - 37.4500 1-Yr Rtn: -

Stock Chart for ORINF

No chart data available.
  • ORINF:US 31.6000
  • 1D
  • 1M
  • 1Y
31.6000
Interactive ORINF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORINF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 23.4054
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 1.2440
Est. PEG Ratio -
Market Cap (M USD) 4,625.45
Shares Outstanding (M) 100.84
30 Day Average Volume 3
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.51%
Cash Dividend (EUR) 1.3000
Dividend Ex-Date 03/25/2015
5 Year Dividend Growth -0.52%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORINF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORINF

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORINF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil